Steven Feinstein to Biomarkers
This is a "connection" page, showing publications Steven Feinstein has written about Biomarkers.
Connection Strength
0.322
-
New advances in noninvasive imaging of the carotid artery: CIMT, contrast-enhanced ultrasound, and vasa vasorum. Curr Cardiol Rep. 2010 Nov; 12(6):497-502.
Score: 0.071
-
Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care. 2009 May; 32(5):932-7.
Score: 0.063
-
Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol. 2004 Jun 03; 93(11A):32C-48C.
Score: 0.045
-
Emerging, noninvasive surrogate markers of atherosclerosis. Curr Atheroscler Rep. 2004 Jan; 6(1):60-8.
Score: 0.044
-
Noninvasive surrogate markers of atherosclerosis. Am J Cardiol. 2002 Mar 07; 89(5A):31C-43C; discussion 43C-44C.
Score: 0.039
-
Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids. Atherosclerosis. 2015 Jul; 241(1):92-9.
Score: 0.024
-
Chronic PM2.5 exposure and inflammation: determining sensitive subgroups in mid-life women. Environ Res. 2014 Jul; 132:168-75.
Score: 0.023
-
Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes. Diabetes. 2007 Mar; 56(3):849-55.
Score: 0.014